These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 22402306
1. Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients. Nielsen SE, Reinhard H, Zdunek D, Hess G, Gutiérrez OM, Wolf M, Parving HH, Jacobsen PK, Rossing P. Diabetes Res Clin Pract; 2012 Jul; 97(1):71-6. PubMed ID: 22402306 [Abstract] [Full Text] [Related]
6. Risk factors for progression of renal disease in patient with diabetic nephropathy. Unsal A, Koc Y, Basturk T, Akgun AO, Sakaci T, Ahbap E. Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):878-83. PubMed ID: 22953635 [Abstract] [Full Text] [Related]
7. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy. Hwang S, Park J, Kim J, Jang HR, Kwon GY, Huh W, Kim YG, Kim DJ, Oh HY, Lee JE. J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450 [Abstract] [Full Text] [Related]
11. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Nosadini R, Velussi M, Brocco E, Bruseghin M, Abaterusso C, Saller A, Dalla Vestra M, Carraro A, Bortoloso E, Sambataro M, Barzon I, Frigato F, Muollo B, Chiesura-Corona M, Pacini G, Baggio B, Piarulli F, Sfriso A, Fioretto P. Diabetes; 2000 Mar; 49(3):476-84. PubMed ID: 10868971 [Abstract] [Full Text] [Related]
12. Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1. Hovind P, Tarnow L, Rossing P, Teerlink T, Stehouwer CD, Emeis JJ, Parving HH. Am J Kidney Dis; 2001 Dec; 38(6):1376-80. PubMed ID: 11728978 [Abstract] [Full Text] [Related]
13. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy. Mise K, Hoshino J, Ueno T, Hazue R, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hayami N, Suwabe T, Sawa N, Fujii T, Hara S, Ohashi K, Takaichi K, Ubara Y. Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683 [Abstract] [Full Text] [Related]
14. Association between serum soluble TNFα receptors and renal dysfunction in type 2 diabetic patients without proteinuria. Miyazawa I, Araki S, Obata T, Yoshizaki T, Morino K, Kadota A, Ugi S, Kawai H, Uzu T, Nishio Y, Koya D, Haneda M, Kashiwagi A, Maegawa H. Diabetes Res Clin Pract; 2011 May; 92(2):174-80. PubMed ID: 21288590 [Abstract] [Full Text] [Related]
15. Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients. Nauta FL, Bakker SJ, van Oeveren W, Navis G, van der Heide JJ, van Goor H, de Jong PE, Gansevoort RT. Am J Kidney Dis; 2011 May; 57(5):733-43. PubMed ID: 21458900 [Abstract] [Full Text] [Related]